Welcome. If you're a registered user, please log-in. If not, please sign-up.

22 days to go - register NOW!

2 Co-Located Events - ADCs + RAbs/Bispecfics

Empowered Antibodies Congress 2013

11 - 13 June 2013 , Hotel Fira Palace, Barcelona, Spain

2 Conferences in 1

1. Recombinant & Bispecific Antibodies

2. Antibody Drug Conjugates

RuiYi enlists the help of Genor to develop its RA candidate in China http://t.co/uBzdPnOWXd 10 hours ago. · reply · retweet · favorite

Proteintech Europe awarded a Quality Certificate for the ISO 9001 2008 standard http://t.co/JNl7nvZQ2o 10 hours ago. · reply · retweet · favorite

Sorrento Therapeutics' antiMRSA program gets NIAID support - Sorrento Therapeutics Inc. announced today that its F... http://t.co/vmwob48Kta 10 hours ago. · reply · retweet · favorite

Sorrento Therapeutics' antiMRSA program gets NIAID support - Sorrento Therapeutics Inc. announced today that its F... http://t.co/CAAjnpyO6V yesterday. · reply · retweet · favorite

Proteintech Europe awarded a Quality Certificate for the ISO 9001 2008 standard http://t.co/XpYgHh5Ir8 yesterday. · reply · retweet · favorite

RuiYi enlists the help of Genor to develop its RA candidate in China http://t.co/ooBijf1pdy yesterday. · reply · retweet · favorite

ASCO combo antibody therapy effective for melanoma - HealthDayConcurrent use of two immune checkpoint antibodiesip... http://t.co/OumYZ7yEbY yesterday. · reply · retweet · favorite

Deals Of The Week Is Keeping Score Valeant Wants Actavis Which Covets Warner Chilcott http://t.co/n5FPklBWui yesterday. · reply · retweet · favorite

San Diego Life Sciences Roundup Optimer Ambit AnaptysBio & More http://t.co/6OipV4viAE yesterday. · reply · retweet · favorite

Cobra Biologics to manufacture DNA vaccine for Vaccibody - Clinical and commercialscale biologics and pharmaceutic... http://t.co/knf2ioVyQX yesterday. · reply · retweet · favorite

Roche creates new award for antibodybased cancer therapy research http://t.co/KK8UA1fTQP yesterday. · reply · retweet · favorite

MorphoSys initiates Phase 2 clinical study of antibody treatment for nonHodgkin's lymphoma http://t.co/WbnwcUwWYE yesterday. · reply · retweet · favorite

MorphoSys initiates Phase 2 clinical study of antibody treatment for nonHodgkin's lymphoma http://t.co/0bJP3LvUZp yesterday. · reply · retweet · favorite

Roche creates new award for antibodybased cancer therapy research http://t.co/vJTS9Ok0zC yesterday. · reply · retweet · favorite

Cobra Biologics to manufacture DNA vaccine for Vaccibody - Clinical and commercialscale biologics and pharmaceutic... http://t.co/PfA668zSxX yesterday. · reply · retweet · favorite

Congress Keynote Speakers

Dr William Olson Senior Vice President, Research & Development Progenics Pharmaceuticals

Dr Jijie Gu Senior Principal Scientist Abbott

Dr Luis Borges Scientific Director, Therapeutic Innovation Unit Amgen Inc

Dr Ezio Bonvini Senior Vice President, Research MacroGenics Inc.

Conference 1: ADCs

Conference 1:Antibody Drug Conjugate Highlights

Building Biosuperiority into Current Antibody Formats
Developing linker and drug combinations for improved ADC performance
Improvements on target selection
Alternative payloads for improved ADC performance
Pre-clinical assessment and characterisation of ADCs
Translation into the clinic: CMC and regulatory hurdles
Achieving clinical success of ADC: Lessons learned
Analytical tools for optimising ADC antibody/drug profiling

Conference 2: RABs/Bispecifics

Conference 2: Recombinant & Bispecific Antibodies Highlights

Antibody Fusion Proteins and Fc Functionality Engineering
Antibody Engineering for Decreased & Immunogenicity
Selecting the Best Bispecific & Multispecific Antibody Format
Clinical Advances for Bispecific Antibodies
How are Alternative Scaffolds Progressing Towards the Clinic
IP and Technology Review- What is Available?

Make the Most of Barcelona

Barcelona has the dynamic and open personality so typical of Mediterranean cities. It is the perfect city to relax in, stroll around and enjoy. Barcelona has its own way of life which makes it unique. Click here to find out more about what Barcelona and how you can make the most of your trip to this beautiful and intriguing city.

The Hotel Fira Palace located in the heart of Montjuic, is one of the most cultural and leisure area. Situated between the famous Gran Via Avenue and the new shopping and entertainment centre ARENAS DE BARCELONA, the hotel is highly popular among business travellers because of its conference facilities and elegant location.

View Latest Programme

(Updated 17 May 2013)

Feeds

Like

View Latest Programme

Request E-Updates

Two Conferences for the Price of One

Two co-located conferences:

1. RABs and Bispecifics

2. Antibody Drug Conjugates

150+ Professionals in Attendance

With growing interest in this market, Empowered Antibodies 2013 offers a innovative and interactive platform for industry professionals to network withh like-minded experts

50+ Industry Case Studies

Practical case studies from leading industry representatives including Genentech, Amgen, Pfizer, MacroGenics, Immunogen, Abbott, MedImmune, Bayer and more

10+ Hours of Networking

With our dedicated drinks reception, high-speed networking and our Congress networking App benefit with dedicated session to meet new clients and set up meetings

Europe's leading Recombinant and Multivalent Antibodies & Antibody Drug Conjugates Conferences

Why Empowered Antibodies Congress is a not to miss event?

Informa's annual Empowered Antibodies Congress is Europe's leading Congress for both industry and academia to discover the latest innovations in protein engineering, enhancing therapeutic properties and learning about the latest pre-clinical and clinical developments of next generation antibodies.

2012 Delegate Job Title Profile

Who will you meet in 2013

Job titles:

Directors
CEOs
CSOs
CTOs
Managers
Group Head
Laboratory Heads
Scientists

Departments:

Protein/Antibody Engineering
R&D
Discovery
Antibody-Drug Conjugates
Pre-Clinical/Clinical Development
CMC & Regulatory
Pharmacology
Production & Manufacturing

Empowered Antibodies Congress TV

Informa Empowered Antibodies Congress - Antibody Drug Conjugates, Boris Gorovitz, Pfizer 02:12

View all

2013 Conference Highlights

Network with 150+ scientists working with novel antibody formats including bispecifics, ADCs and recombinant antibodies: Benchmark against cutting-edge programmes and hear the latest in preclinical and clinical development

Access 2 conferences in 1 and benefit from networking with 2 focused delegate audiences

Get involved in high speed networking to make more business contacts in one session than you can make in 6 months!

Key focuses on some of the hottest topics in the antibody arena: Engineering tools, clinical updates on applications of bispecifics & novel therapeutic targets, manufacturability and developability issues of all next generation products

Up to 10+ hours of dedicated networking time in our dedicated networking and Exhibition Hall

Drinks reception at the end of the first conference day to allow for informal networking and to consolidate new contacts

Structured poster session allowing the latest antibody engineering and next-generation therapeutic data to be presented

Exhibitor

Contact us now for more info

For further information about contributing at Engineered Antibodies or Bispecifics, please contact

Martin Cheung: Tel. +44 (0)20 7017 4938 email: martin.cheung@informa.com

2013 Congress Sponsors

Exhibitors

QUICK LINKS

Informa Life Sciences

This site is owned and operated by Informa plc

Informa plc Company number 102786, Registered in Jersey, Registered office address: Lime Grove House, Green Street, St Helier, Jersey, JE1 2ST, Address: Gubelstrasse 11, CH-6300, Zug, Switzerland.

EVENTS BY SECTOR

EVENTS BY TYPE

Conferences

XTmotion Conference Website Solutions, Website Development & Support